FIELD: medicine. SUBSTANCE: method involves applying autohemotherapy. Fibrinolytic agent is administered to produce constant blood layer on anterior eye surface until corneal epithelialization takes place. Heparin is administered as the fibrinolytic agent in particular cases at a dose of 1000 units twice a day. Holes in conjunctiva are produced in advance in particular cases to introduce fibrinolytic agent solution. EFFECT: enhanced effectiveness of treatment; accelerated and full-scale recovery. 3 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF INFLAMMATORY DISEASES OF CORNEA | 1996 |
|
RU2127571C1 |
METHOD FOR TREATING COMPLICATED PURULENT CORNEAL ULCER | 2006 |
|
RU2309710C1 |
METHOD OF TREATING INFLAMMATORY OR DYSTROPHIC EYE DISEASES | 2019 |
|
RU2714193C1 |
METHOD FOR TREATING THE CASES OF POST-INFLAMMATION BULLOUS KERATOPATHY | 2000 |
|
RU2165747C1 |
METHOD OF RECURRING CORNEAL EROSION TREATMENT | 2008 |
|
RU2365358C1 |
METHOD OF TREATING FUNGAL KERATITIS AFTER PENETRATING KERATOPLASTY | 2022 |
|
RU2820070C2 |
METHOD FOR TREATING NEUROTROPHIC HARE EYE KERATITIS CASES AGGRAVATED WITH CENTRAL OPTICAL CORNEA ZONE INJURY | 2005 |
|
RU2299048C2 |
METHOD FOR EYE INFLAMMATORY DISEASES TREATMENT | 1988 |
|
RU2008857C1 |
MICRODIATHERMOPLASTY TECHNIQUE FOR TREATING INFECTIOUS CORNEAL ULCERS | 2011 |
|
RU2453296C1 |
METHOD OF TREATING DEEP STROMAL KERATITES | 2010 |
|
RU2440801C1 |
Authors
Dates
2004-01-10—Published
2002-09-27—Filed